The fore­cast for biotech IPOs in 2017? Not near­ly as hot as the in­dus­try would like

 

Last year on­ly 28 bio­phar­ma com­pa­nies man­aged to com­plete an IPO in the US, the worst record since the bad old days of 2012 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.